Skip to content
July 22, 2025
  • A deeper dive into drug revenue and cost
  • Dominique Wells, Conduit Health Partners
  • ACA Marketplace Insurers Proposing 15% Median Premium Increase in 2026
  • Victoria DeFrancesco Soto Joins KFF Board of Trustees

Medical Article

Newsletter
Random News
  • Sample Page
Headlines
  • A deeper dive into drug revenue and cost

    2 hours ago
  • Dominique Wells, Conduit Health Partners

    4 hours ago
  • ACA Marketplace Insurers Proposing 15% Median Premium Increase in 2026

    8 hours ago
  • Victoria DeFrancesco Soto Joins KFF Board of Trustees

    9 hours ago
  • Roche Reports Mixed Data for Drug Trying to Jump on the Biologic Bandwagon in COPD

    13 hours ago
  • New Policy Bars Many Lawfully Present and Undocumented Immigrants from a Broad Range of Federal Health and Social Supports

    15 hours ago
  • Articles

Trump Says He’ll Stop Health Care Fraudsters. Last Time, He Let Them Walk.

4 months ago015 mins

Five years ago, the CEO of one of the largest pain clinic companies in the Southeast was sentenced to more than three years in prison after being convicted in a $4 million illegal kickback scheme. But after just four months behind bars, John Estin Davis walked free. President Donald Trump commuted Davis’ sentence in the…

Read More
  • Articles

Montana May Start Collecting Immunization Data Again Amid US Measles Outbreak

4 months ago013 mins

When epidemiologist Sophia Newcomer tries to evaluate how well Montana might be able to ward off the measles outbreak spreading across the U.S., she doesn’t have much data to work with. A federal state-by-state survey last year showed that just over 86% of Montana’s 2-year-olds had recently received the measles, mumps, and rubella immunization. That…

Read More
  • Medicine

America’s Aging Crossroads: Will We Rise to the Challenge or Fall Behind?

4 months ago01 mins

This is not just about today’s older adults — it’s about the next 50 years. If we design a smarter, more sustainable system now, we will all benefit when our time comes. The post America’s Aging Crossroads: Will We Rise to the Challenge or Fall Behind? appeared first on MedCity News.

Read More
  • Medicine

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

4 months ago01 mins

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University…

Read More
  • Other

Drugmakers Expedite Shipments to the U.S. Ahead of Tariffs

4 months ago01 mins

A new poll has industry leaders warning that tariffs will disrupt U.S. healthcare costs and supply chain stability

Read More
  • Medicine

Talkspace Introduces AI-Powered Personalized Podcasts

4 months ago01 mins

Talkspace introduced Talkcast on Monday, an AI-powered feature that allows therapists to generate personalized podcast episodes for clients. The post Talkspace Introduces AI-Powered Personalized Podcasts appeared first on MedCity News.

Read More
  • Other

Health Net’s Innovative Care Transitions Program Moves the Needle

4 months ago01 mins

A pioneering program is improving patient outcomes in and outside hospitals

Read More
  • Other

How Is Robotic Process Automation Evolving in Healthcare?

4 months ago01 mins

Baker Tilly’s David Hickey says that with health systems under financial pressure, the use of ‘digital workers’ is going to make more sense moving forward

Read More
  • Other

Telemedicine Advocacy Group Buys Digital Therapeutics Alliance

4 months ago01 mins

Goal is to create a ‘unified voice to shape healthcare policies, ensuring that telehealth and digital therapeutics remain integral components of the U.S. healthcare system’

Read More
  • Medicine

Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal

4 months ago01 mins

Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertex’s entry into type 1 diabetes. The post Vertex Cell Therapy Misses in…

Read More
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 358

Recent Posts

  • A deeper dive into drug revenue and cost
  • Dominique Wells, Conduit Health Partners
  • ACA Marketplace Insurers Proposing 15% Median Premium Increase in 2026
  • Victoria DeFrancesco Soto Joins KFF Board of Trustees
  • Roche Reports Mixed Data for Drug Trying to Jump on the Biologic Bandwagon in COPD

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2025. Powered By BlazeThemes.